[96a5a0]: / output / allTrials / identified / NCT00789373_identified.json

Download this file

806 lines (806 with data), 37.6 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
{
"info": {
"nct_id": "NCT00789373",
"official_title": "A Phase 3, Double-Blind, Placebo-Controlled Study of Maintenance Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Immediately Following Induction Treatment With Pemetrexed + Cisplatin for Advanced Non-squamous Non-Small Cell Lung Cancer.",
"inclusion_criteria": "Healthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "",
"miscellaneous_criteria": "Inclusion Criteria for the Induction Phase:\n\n* You must sign an informed consent document for clinical research.\n* You must have Stage IIIB or IV nonsquamous Non-Small Cell Lung Cancer.\n* You must at least be able to be physically mobile, take care of yourself, and must be up and about and able to perform light activities such as light housework or office work.\n* You are allowed to have had prior radiation therapy as long as it was not to more than 25% of the bone marrow and did not include the whole pelvis. Thoracic radiation must be completed more than 30 days before the study. You must be recovered from the toxic effects (except hair loss).\n* You must have at least 1 measurable tumor lesion according to the Response Evaluation Criteria in Solid Tumors (RECIST) guidelines or disease that can be evaluated by computed tomography (CT) Scan.\n* Your test results assessing the function of your blood forming tissue, kidneys, and liver must be satisfactory.\n* You must be 18 years of age or older.\n* Women must be sterile, postmenopausal or on contraception and men must be on contraception or sterile (e.g. post-vasectomy).\n\nExclusion Criteria for the Induction Phase:\n\n* You cannot have squamous cell and/or mixed small cell, non-small cell lung cancer\n* You cannot have received other investigational drugs within the last 30 days of entering the trial.\n* You cannot have previously completed or withdrawn from this study or any other study investigating pemetrexed.\n* You cannot have other serious on-going illnesses including active infections.\n* You cannot have a serious cardiac condition, such as a heart attack, angina, or heart disease within 6 months of entering the trial.\n* You cannot have had another form of cancer other than superficial basal cell and superficial squamous (skin) cell cancer, or carcinoma in situ of the cervix within the last 5 years. Patients with a history of low-grade (Gleason score less than or equal to 6) localized prostate cancer will be eligible even if diagnosed less than 5 years ago.\n* You cannot have known central nervous system (CNS) metastases, other than treated, stable brain metastasis.\n* You cannot be receiving nor have received any prior systemic anticancer therapy for lung cancer (including chemotherapy given after surgery in early-stage treatment).\n* You cannot have clinically significant third-space fluid collections (e.g. ascites or pleural effusions that cannot be controlled by drainage or other procedures).\n* You cannot have received a recent (within 30 days) or are receiving a yellow fever vaccination.\n* You are unable to stop taking more than 1.3 grams of aspirin on a daily basis or other non-steroidal anti-inflammatory drugs (NSAIDs).\n* You are unable or unwilling to take folic acid, injections of vitamin B12, or corticosteroids.\n* You cannot be pregnant or breastfeeding.\n\nInclusion criteria at Randomization for the Maintenance Phase:\n\n* You must at least be able to be physically mobile, take care of yourself, and must be up and about and able to perform light activities such as light housework or office work.\n* You must have documented radiographic evidence of a tumor response of complete response (CR), partial response (PR), or stable disease (SD) according to the Response Evaluation Criteria in Solid Tumors (RECIST) guidelines. Tumor assessment must occur between Cycle 4 (Day 1) of induction therapy and the date of randomization. This response does not have to be confirmed in order for the patient to be randomized to the maintenance phase."
},
"inclusion_lines": [
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [],
"miscellaneous_lines": [
{
"line": "* You must sign an informed consent document for clinical research.",
"criterions": [
{
"exact_snippets": "sign an informed consent document",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
}
]
}
]
},
{
"line": "* You must have Stage IIIB or IV nonsquamous Non-Small Cell Lung Cancer.",
"criterions": [
{
"exact_snippets": "Stage IIIB or IV",
"criterion": "cancer stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"IIIB",
"IV"
]
}
]
},
{
"exact_snippets": "nonsquamous Non-Small Cell Lung Cancer",
"criterion": "cancer type",
"requirements": [
{
"requirement_type": "type",
"expected_value": "nonsquamous Non-Small Cell Lung Cancer"
}
]
}
]
},
{
"line": "* You must at least be able to be physically mobile, take care of yourself, and must be up and about and able to perform light activities such as light housework or office work.",
"criterions": [
{
"exact_snippets": "be physically mobile",
"criterion": "physical mobility",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
},
{
"exact_snippets": "take care of yourself",
"criterion": "self-care ability",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
},
{
"exact_snippets": "be up and about",
"criterion": "general activity level",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
},
{
"exact_snippets": "perform light activities such as light housework or office work",
"criterion": "ability to perform light activities",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "* You are allowed to have had prior radiation therapy as long as it was not to more than 25% of the bone marrow and did not include the whole pelvis. Thoracic radiation must be completed more than 30 days before the study. You must be recovered from the toxic effects (except hair loss).",
"criterions": [
{
"exact_snippets": "prior radiation therapy",
"criterion": "prior radiation therapy",
"requirements": [
{
"requirement_type": "allowance",
"expected_value": true
}
]
},
{
"exact_snippets": "not to more than 25% of the bone marrow",
"criterion": "radiation to bone marrow",
"requirements": [
{
"requirement_type": "percentage",
"expected_value": {
"operator": "<=",
"value": 25,
"unit": "%"
}
}
]
},
{
"exact_snippets": "did not include the whole pelvis",
"criterion": "radiation to pelvis",
"requirements": [
{
"requirement_type": "inclusion",
"expected_value": false
}
]
},
{
"exact_snippets": "Thoracic radiation must be completed more than 30 days before the study",
"criterion": "thoracic radiation completion",
"requirements": [
{
"requirement_type": "time before study",
"expected_value": {
"operator": ">",
"value": 30,
"unit": "days"
}
}
]
},
{
"exact_snippets": "recovered from the toxic effects (except hair loss)",
"criterion": "recovery from toxic effects",
"requirements": [
{
"requirement_type": "recovery",
"expected_value": true
}
]
}
]
},
{
"line": "* You must have at least 1 measurable tumor lesion according to the Response Evaluation Criteria in Solid Tumors (RECIST) guidelines or disease that can be evaluated by computed tomography (CT) Scan.",
"criterions": [
{
"exact_snippets": "at least 1 measurable tumor lesion according to the Response Evaluation Criteria in Solid Tumors (RECIST) guidelines",
"criterion": "measurable tumor lesion",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "N/A"
}
},
{
"requirement_type": "measurement_guideline",
"expected_value": "RECIST"
}
]
},
{
"exact_snippets": "disease that can be evaluated by computed tomography (CT) Scan",
"criterion": "disease evaluable by CT Scan",
"requirements": [
{
"requirement_type": "evaluation_method",
"expected_value": "CT Scan"
}
]
}
]
},
{
"line": "* Your test results assessing the function of your blood forming tissue, kidneys, and liver must be satisfactory.",
"criterions": [
{
"exact_snippets": "function of your blood forming tissue",
"criterion": "blood forming tissue function",
"requirements": [
{
"requirement_type": "function",
"expected_value": "satisfactory"
}
]
},
{
"exact_snippets": "function of your ... kidneys",
"criterion": "kidney function",
"requirements": [
{
"requirement_type": "function",
"expected_value": "satisfactory"
}
]
},
{
"exact_snippets": "function of your ... liver",
"criterion": "liver function",
"requirements": [
{
"requirement_type": "function",
"expected_value": "satisfactory"
}
]
}
]
},
{
"line": "* You must be 18 years of age or older.",
"criterions": [
{
"exact_snippets": "18 years of age or older",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Women must be sterile, postmenopausal or on contraception and men must be on contraception or sterile (e.g. post-vasectomy).",
"criterions": [
{
"exact_snippets": "Women must be sterile",
"criterion": "female sterility",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Women must be ... postmenopausal",
"criterion": "female postmenopausal status",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Women must be ... on contraception",
"criterion": "female contraception",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "men must be on contraception",
"criterion": "male contraception",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "men must be ... sterile (e.g. post-vasectomy)",
"criterion": "male sterility",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* You cannot have squamous cell and/or mixed small cell, non-small cell lung cancer",
"criterions": [
{
"exact_snippets": "squamous cell",
"criterion": "squamous cell lung cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "mixed small cell, non-small cell lung cancer",
"criterion": "mixed small cell, non-small cell lung cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* You cannot have received other investigational drugs within the last 30 days of entering the trial.",
"criterions": [
{
"exact_snippets": "You cannot have received other investigational drugs within the last 30 days",
"criterion": "receipt of investigational drugs",
"requirements": [
{
"requirement_type": "time since last receipt",
"expected_value": {
"operator": ">=",
"value": 30,
"unit": "days"
}
}
]
}
]
},
{
"line": "* You cannot have previously completed or withdrawn from this study or any other study investigating pemetrexed.",
"criterions": [
{
"exact_snippets": "You cannot have previously completed or withdrawn from this study",
"criterion": "previous participation in this study",
"requirements": [
{
"requirement_type": "participation",
"expected_value": false
}
]
},
{
"exact_snippets": "any other study investigating pemetrexed",
"criterion": "previous participation in other studies investigating pemetrexed",
"requirements": [
{
"requirement_type": "participation",
"expected_value": false
}
]
}
]
},
{
"line": "* You cannot have other serious on-going illnesses including active infections.",
"criterions": [
{
"exact_snippets": "other serious on-going illnesses",
"criterion": "serious on-going illnesses",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "active infections",
"criterion": "active infections",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* You cannot have a serious cardiac condition, such as a heart attack, angina, or heart disease within 6 months of entering the trial.",
"criterions": [
{
"exact_snippets": "serious cardiac condition, such as a heart attack, angina, or heart disease",
"criterion": "serious cardiac condition",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "within 6 months of entering the trial",
"criterion": "time since serious cardiac condition",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
}
]
},
{
"line": "* You cannot have had another form of cancer other than superficial basal cell and superficial squamous (skin) cell cancer, or carcinoma in situ of the cervix within the last 5 years. Patients with a history of low-grade (Gleason score less than or equal to 6) localized prostate cancer will be eligible even if diagnosed less than 5 years ago.",
"criterions": [
{
"exact_snippets": "You cannot have had another form of cancer other than superficial basal cell and superficial squamous (skin) cell cancer, or carcinoma in situ of the cervix within the last 5 years.",
"criterion": "history of cancer",
"requirements": [
{
"requirement_type": "type",
"expected_value": [
"superficial basal cell",
"superficial squamous (skin) cell",
"carcinoma in situ of the cervix"
]
},
{
"requirement_type": "time frame",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 5,
"unit": "years"
}
]
}
}
]
},
{
"exact_snippets": "Patients with a history of low-grade (Gleason score less than or equal to 6) localized prostate cancer will be eligible even if diagnosed less than 5 years ago.",
"criterion": "history of prostate cancer",
"requirements": [
{
"requirement_type": "grade",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 6,
"unit": "Gleason score"
}
]
}
},
{
"requirement_type": "localization",
"expected_value": "localized"
}
]
}
]
},
{
"line": "* You cannot have known central nervous system (CNS) metastases, other than treated, stable brain metastasis.",
"criterions": [
{
"exact_snippets": "known central nervous system (CNS) metastases",
"criterion": "central nervous system (CNS) metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "treated, stable brain metastasis",
"criterion": "brain metastasis",
"requirements": [
{
"requirement_type": "treatment status",
"expected_value": "treated"
},
{
"requirement_type": "stability",
"expected_value": "stable"
}
]
}
]
},
{
"line": "* You cannot be receiving nor have received any prior systemic anticancer therapy for lung cancer (including chemotherapy given after surgery in early-stage treatment).",
"criterions": [
{
"exact_snippets": "You cannot be receiving ... any prior systemic anticancer therapy for lung cancer",
"criterion": "systemic anticancer therapy for lung cancer",
"requirements": [
{
"requirement_type": "current status",
"expected_value": false
}
]
},
{
"exact_snippets": "You cannot ... have received any prior systemic anticancer therapy for lung cancer",
"criterion": "prior systemic anticancer therapy for lung cancer",
"requirements": [
{
"requirement_type": "history",
"expected_value": false
}
]
}
]
},
{
"line": "* You cannot have received a recent (within 30 days) or are receiving a yellow fever vaccination.",
"criterions": [
{
"exact_snippets": "received a recent (within 30 days) ... yellow fever vaccination",
"criterion": "yellow fever vaccination",
"requirements": [
{
"requirement_type": "recency",
"expected_value": {
"operator": "<=",
"value": 30,
"unit": "days"
}
},
{
"requirement_type": "current status",
"expected_value": false
}
]
}
]
},
{
"line": "* You are unable to stop taking more than 1.3 grams of aspirin on a daily basis or other non-steroidal anti-inflammatory drugs (NSAIDs).",
"criterions": [
{
"exact_snippets": "unable to stop taking more than 1.3 grams of aspirin on a daily basis",
"criterion": "aspirin intake",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 1.3,
"unit": "grams per day"
}
}
]
},
{
"exact_snippets": "unable to stop taking ... other non-steroidal anti-inflammatory drugs (NSAIDs)",
"criterion": "NSAID intake",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* You are unable or unwilling to take folic acid, injections of vitamin B12, or corticosteroids.",
"criterions": [
{
"exact_snippets": "unable or unwilling to take folic acid",
"criterion": "folic acid intake",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
}
]
},
{
"exact_snippets": "unable or unwilling to take ... injections of vitamin B12",
"criterion": "vitamin B12 injections",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
}
]
},
{
"exact_snippets": "unable or unwilling to take ... corticosteroids",
"criterion": "corticosteroids intake",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
}
]
}
]
},
{
"line": "* You cannot be pregnant or breastfeeding.",
"criterions": [
{
"exact_snippets": "cannot be pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "cannot be ... breastfeeding",
"criterion": "breastfeeding",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* You must at least be able to be physically mobile, take care of yourself, and must be up and about and able to perform light activities such as light housework or office work.",
"criterions": [
{
"exact_snippets": "be physically mobile",
"criterion": "physical mobility",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
},
{
"exact_snippets": "take care of yourself",
"criterion": "self-care ability",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
},
{
"exact_snippets": "be up and about",
"criterion": "general activity level",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
},
{
"exact_snippets": "perform light activities such as light housework or office work",
"criterion": "ability to perform light activities",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "* You must have documented radiographic evidence of a tumor response of complete response (CR), partial response (PR), or stable disease (SD) according to the Response Evaluation Criteria in Solid Tumors (RECIST) guidelines. Tumor assessment must occur between Cycle 4 (Day 1) of induction therapy and the date of randomization. This response does not have to be confirmed in order for the patient to be randomized to the maintenance phase.",
"criterions": [
{
"exact_snippets": "documented radiographic evidence of a tumor response of complete response (CR), partial response (PR), or stable disease (SD) according to the Response Evaluation Criteria in Solid Tumors (RECIST) guidelines",
"criterion": "tumor response",
"requirements": [
{
"requirement_type": "evidence",
"expected_value": "documented radiographic evidence"
},
{
"requirement_type": "response type",
"expected_value": [
"complete response (CR)",
"partial response (PR)",
"stable disease (SD)"
]
},
{
"requirement_type": "guidelines",
"expected_value": "Response Evaluation Criteria in Solid Tumors (RECIST)"
}
]
},
{
"exact_snippets": "Tumor assessment must occur between Cycle 4 (Day 1) of induction therapy and the date of randomization",
"criterion": "tumor assessment timing",
"requirements": [
{
"requirement_type": "timing",
"expected_value": "between Cycle 4 (Day 1) of induction therapy and the date of randomization"
}
]
}
]
}
],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": [
{
"line": "Inclusion Criteria for the Induction Phase:",
"criterions": []
},
{
"line": "Exclusion Criteria for the Induction Phase:",
"criterions": []
},
{
"line": "* You cannot have clinically significant third-space fluid collections (e.g. ascites or pleural effusions that cannot be controlled by drainage or other procedures).",
"criterions": [
{
"exact_snippets": "clinically significant third-space fluid collections (e.g. ascites or pleural effusions)",
"criterion": "third-space fluid collections",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "clinically significant"
}
]
},
{
"exact_snippets": "cannot be controlled by drainage or other procedures",
"criterion": "control of third-space fluid collections",
"requirements": [
{
"requirement_type": "controllability",
"expected_value": false
}
]
}
]
},
{
"line": "Inclusion criteria at Randomization for the Maintenance Phase:",
"criterions": []
}
]
}